However, recent result from by using knockout mice and selective antagonists indicated that prostanoid receptor, especially PGE2 enhances angiogenesis and tumor growth. Here, we summarize significant of PGE2 signaling via EP3 receptors which exists on the stroma but on tumor cells. An EP3 receptor antagonist may be a candidate of chemopreventive agents for malignant tumor.
Introduction
The prostanoid receptor subtype in angiogenesis Host stromal prostanoid receptor signaling contributes to tumor-growth and angiogenesis Prostanoid receptor antagonist has possibility to preventive approach for cancer and the control of inflammatory response and tumor angiogenesis
